source
- Caribou Biosciences halts pipeline and announces major workforce cutCaribou Biosciences, a Bay Area biotech that develops off-the-shelf CAR-T cell therapies, said it will stop all clinical development and begin a substantial workforce reduction. The company, which…
- AstraZeneca launches $1 billion R&D hub in Boston’s Kendall SquareAstraZeneca opened a new research and development site in Kendall Square, Boston, marking a $1 billion investment in the U.S. biotech corridor. The Boston location underscores the company’s commit…